Unique submission

  Autoinjectors are devices that deliver a pre-measured dose of medication into the body through the skin. They are used to administer a variety of medications, including epinephrine, insulin, and vaccines. Autoinjectors are designed to be easy to use, even by people with limited dexterity. Regional Overview Europe is the second largest market for autoinjectors, accounting for 27.8% of the market share in 2022. The high prevalence of chronic diseases in the region, such as diabetes and asthma, is driving the demand for autoinjectors. Germany is the largest market for autoinjectors in Europe, followed by France and Italy. Asia Pacific is the fastest growing market for autoinjectors, with a CAGR of 22.8% from 2023 to 2028. This is due to the rising prevalence of chronic diseases in the region, such as diabetes and asthma, and the increasing disposable income of people in the region. China is the largest market for autoinjec...

  The orthopedic devices market is a large and growing market. It is estimated to be worth $61.02 billion in 2032, growing at a CAGR of 6.5% from 2023 to 2032. The growth of the market is driven by a number of factors, including: The increasing prevalence of orthopedic disorders: Orthopedic disorders are a major cause of disability worldwide. The most common orthopedic disorders are osteoarthritis, osteoporosis, and rheumatoid arthritis. The prevalence of these disorders is expected to increase in the coming years due to the aging population and the increasing obesity rates. The aging population: The global population is aging, and this is leading to an increase in the number of people with orthopedic disorders. The aging population is also more likely to suffer from falls and other injuries that can lead to orthopedic problems. Technological advancements in orthopedic devices: There have been major advancements in the developme...

 The global saliva collection & diagnostics market share is expected to reach $6.29 billion by 2032, growing at a CAGR of 11.2% from 2023 to 2032. The market is driven by the increasing demand for non-invasive and convenient diagnostic tests, the rising prevalence of chronic diseases, and the technological advancements in saliva collection and diagnostics. The market is segmented by product, application, and end-user. By product, the market is segmented into saliva collection devices, saliva diagnostic kits, and saliva testing services. Saliva collection devices are the largest segment of the market, and they are expected to continue to dominate the market in the coming years. This is due to the increasing demand for convenient and non-invasive ways to collect saliva samples. The key players in the saliva collection & diagnostics market include Thermo Fisher Scientific, Neogen Corporation, Abbott, Sarstedt AG & Co.KG, Autogen, Inc., Oasis Diagnostics, Porex, Salimet...

  The laboratory information system (LIS) market is expected to grow at a CAGR of 9.50% from 2023 to 2030, reaching a value of USD 4.0 billion by 2030. The growth of the market is driven by the increasing demand for accurate and timely laboratory results, the need to improve laboratory efficiency, and the rising adoption of cloud-based LIS solutions. The key players in the LIS market are: Cerner Corporation Epic Systems Corporation McKesson Corporation LabVantage Solutions Siemens Healthineers Sysmex Corporation InterSystems Corporation Sunquest Information Systems ARUP Laboratories OraSure Technologies Mindray Medical International Limited These companies are developing and providing LIS solutions to hospitals, independent laboratories, and POLs. LIS are software systems that are used to manage laboratory data and processes. They are used to collect, store, and track laboratory results, as well as to automate laboratory workflows. LIS can help to im...

  Commercial pharmaceutical analytics is the use of analytical software to manage and analyze biological and biomedical data from life science industries like hospitals, laboratories, and pharmaceutical companies. It helps to improve the efficiency and effectiveness of pharmaceutical research and development, marketing, and sales. The commercial pharmaceutical analytics market is expected to grow at a CAGR of 18.90% from 2023 to 2032. The growth of the market is driven by the increasing demand for new drugs and therapies, the need to improve the efficiency of drug development, and the increasing use of data analytics in the pharmaceutical industry. The key players in the commercial pharmaceutical analytics market are: IBM SAS Institute Oracle Microsoft SAP 3M IQVIA ICON plc PAREXEL International Corporation Bristol-Myers Squibb Company Pfizer Inc. These companies are developing and providing commercial pharmaceutical analytics solutions to pharmaceut...

The global enteral feeding devices market is expected to grow at a compound annual growth rate (CAGR) of 5.10% from 2023 to 2032. The market is being driven by the increasing prevalence of chronic diseases, such as cancer, stroke, and neurological disorders, which can lead to difficulty in swallowing or digesting food. Enteral feeding is a method of providing nutrition to people who cannot or will not eat by mouth. It is typically done through a tube that is inserted through the nose or mouth and into the stomach or small intestine. There are two main types of enteral feeding devices: Nasogastric tubes: These tubes are inserted through the nose and into the stomach. They are the most common type of enteral feeding device. Gastrostomy tubes: These tubes are inserted directly into the stomach through a small incision in the abdomen. They are more difficult to insert than nasogastric tubes, but they are less likely to cause complications. Enteral feeding devices can be used for a variet...

The global healthcare analytics market is expected to grow at a compound annual growth rate (CAGR) of 14.20% by 2032. The market is being driven by the increasing demand for data-driven decision-making in healthcare, the growing availability of healthcare data, and the technological advancements in healthcare analytics. Here are some of the key factors driving the growth of the healthcare analytics market: Increasing demand for data-driven decision-making in healthcare: Healthcare organizations are increasingly using data analytics to make better decisions about patient care, population health management, and resource allocation. Growing availability of healthcare data: The amount of healthcare data is growing exponentially due to the increasing use of electronic health records (EHRs), wearable devices, and other data sources. Technological advancements in healthcare analytics: There are a number of technological advancements in healthcare analytics, such as artificial intelligence (...